Table 1.

Demographic characteristics of the cohort

		Total (N=540)	Alive (N=468)	Dead (N=39)	Lost to follow up, Transferred, or Withdrew from study (N=33)
Female, N (%)		324 (60%)	294 (63%)	15 (38%)	15 (45%)
Age, years, median (IQR)		36 (30–44)	36 (30–44)	36 (29–48)	33 (28–40)
CD4 T cell count, cells/µL median, (IQR)		155 (72–206)	158 (79–210)	66 (18–159)	106 (61–196)
Hemoglobin, mg/dL mean (S.D.)		11.7 (2.2)	11.8 (2.1)	8.9 (2.2)	11.3 (2.4)
WHO Stage, N (%)
I		38 (7%)	36 (8%)	1 (3%)	1 (4%)
II		183 (35%)	174 (37%)	2 (6%)	7 (26%)
III		214 (40%)	188 (40%)	12 (34%)	14 (52%)
IV		95 (18%)	70 (15%)	20 (57%)	5 (19%)
missing		10	0	4	6
TB at baseline (N, %)		59 (10.9%)	41 (8.8%)	12 (30.8%)	6 (18.2%)
CrAg positive at baseline (N, %)		12 (2.2%)	5 (10.7%)	3 (7.7%)	4 (12.1%)

N=Number; IQR= interquartile range; SD=standard deviation;